177 research outputs found
Single-shot qubit readout in circuit Quantum Electrodynamics
The future development of quantum information using superconducting circuits
requires Josephson qubits [1] with long coherence times combined to a
high-fidelity readout. Major progress in the control of coherence has recently
been achieved using circuit quantum electrodynamics (cQED) architectures [2,
3], where the qubit is embedded in a coplanar waveguide resonator (CPWR) which
both provides a well controlled electromagnetic environment and serves as qubit
readout. In particular a new qubit design, the transmon, yields reproducibly
long coherence times [4, 5]. However, a high-fidelity single-shot readout of
the transmon, highly desirable for running simple quantum algorithms or measur-
ing quantum correlations in multi-qubit experiments, is still lacking. In this
work, we demonstrate a new transmon circuit where the CPWR is turned into a
sample-and-hold detector, namely a Josephson Bifurcation Amplifer (JBA) [6, 7],
which allows both fast measurement and single-shot discrimination of the qubit
states. We report Rabi oscillations with a high visibility of 94% together with
dephasing and relaxation times longer than 0:5 \mu\s. By performing two
subsequent measurements, we also demonstrate that this new readout does not
induce extra qubit relaxation.Comment: 14 pages including 4 figures, preprint forma
Quantum feedback control of a superconducting qubit: Persistent Rabi oscillations
The act of measurement bridges the quantum and classical worlds by projecting
a superposition of possible states into a single, albeit probabilistic,
outcome. The time-scale of this "instantaneous" process can be stretched using
weak measurements so that it takes the form of a gradual random walk towards a
final state. Remarkably, the interim measurement record is sufficient to
continuously track and steer the quantum state using feedback. We monitor the
dynamics of a resonantly driven quantum two-level system -- a superconducting
quantum bit --using a near-noiseless parametric amplifier. The high-fidelity
measurement output is used to actively stabilize the phase of Rabi
oscillations, enabling them to persist indefinitely. This new functionality
shows promise for fighting decoherence and defines a path for continuous
quantum error correction.Comment: Manuscript: 5 Pages and 3 figures ; Supplementary Information: 9
pages and 3 figure
Assessing emergency medical care in low income countries: A pilot study from Pakistan
Background: Emergency Medical Care is an important component of health care system. Unfortunately it is however, ignored in many low income countries. We assessed the availability and quality of facility-based emergency medical care in the government health care system at district level in a low income country - Pakistan. Methods: We did a quantitative pilot study of a convenience sample of 22 rural and 20 urban health facilities in 2 districts - Faisalabad and Peshawar - in Pakistan. The study consisted of three separate cross-sectional assessments of selected community leaders, health care providers, and health care facilities. Three data collection instruments were created with input from existing models for facility assessment such as those used by the Joint Commission of Accreditation of Hospitals and the National Center for Health Statistics in USA and the Medical Research Council in Pakistan. Results: The majority of respondents 43/44(98%), in community survey were not satisfied with the emergency care provided. Most participants 36/44(82%) mentioned that they will not call an ambulance in health related emergency because it does not function properly in the government system. The expenses on emergency care for the last experience were reported to be less than 5,000 Pakistani Rupees (equivalent to US$ 83) for 19/29(66%) respondents. Most health care providers 43/44(98%) were of the opinion that their facilities were inadequately equipped to treat emergencies. The majority of facilities 31/42(74%) had no budget allocated for emergency care. A review of medications and equipment available showed that many critical supplies needed in an emergency were not found in these facilities. Conclusion: Assessment of emergency care should be part of health systems analysis in Pakistan. Multiple deficiencies in emergency care at the district level in Pakistan were noted in our study. Priority should be given to make emergency care responsive to needs in Pakistan. Specific efforts should be directed to equip emergency care at district facilities and to organize an ambulance network
Management of intracranial tuberculous mass lesions: How long should we treat for? [version 2; peer review: 1 approved, 2 approved with reservations]
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence and HIV prevalence. The diagnosis of such lesions, which include tuberculoma and tuberculous abscesses, is often presumptive and based on radiological features, supportive evidence of TB elsewhere and response to TB treatment. However, the treatment response is unpredictable, with lesions frequently enlarging paradoxically or persisting for many years despite appropriate TB treatment and corticosteroid therapy. Most international guidelines recommend a 9-12 month course of TB treatment for central nervous system TB when the infecting Mycobacterium tuberculosis (M.tb) strain is sensitive to first-line drugs. However, there is variation in opinion and practice with respect to the duration of TB treatment in patients with tuberculomas or tuberculous abscesses. A major reason for this is the lack of prospective clinical trial evidence. Some experts suggest continuing treatment until radiological resolution of enhancing lesions has been achieved, but this may unnecessarily expose patients to prolonged periods of potentially toxic drugs. It is currently unknown whether persistent radiological enhancement of intracranial tuberculomas after 9-12 months of treatment represents active disease, inflammatory response in a sterilized lesion or merely revascularization. The consequences of stopping TB treatment prior to resolution of lesional enhancement have rarely been explored. These important issues were discussed at the 3 International Tuberculous Meningitis Consortium meeting. Most clinicians were of the opinion that continued enhancement does not necessarily represent treatment failure and that prolonged TB therapy was not warranted in patients presumably infected with M.tb strains susceptible to first-line drugs. In this manuscript we highlight current medical treatment practices, benefits and disadvantages of different TB treatment durations and the need for evidence-based guidelines regarding the treatment duration of patients with intracranial tuberculous mass lesions
Utilisation of an operative difficulty grading scale for laparoscopic cholecystectomy
Background
A reliable system for grading operative difficulty of laparoscopic cholecystectomy would standardise description of findings and reporting of outcomes. The aim of this study was to validate a difficulty grading system (Nassar scale), testing its applicability and consistency in two large prospective datasets.
Methods
Patient and disease-related variables and 30-day outcomes were identified in two prospective cholecystectomy databases: the multi-centre prospective cohort of 8820 patients from the recent CholeS Study and the single-surgeon series containing 4089 patients. Operative data and patient outcomes were correlated with Nassar operative difficultly scale, using Kendall’s tau for dichotomous variables, or Jonckheere–Terpstra tests for continuous variables. A ROC curve analysis was performed, to quantify the predictive accuracy of the scale for each outcome, with continuous outcomes dichotomised, prior to analysis.
Results
A higher operative difficulty grade was consistently associated with worse outcomes for the patients in both the reference and CholeS cohorts. The median length of stay increased from 0 to 4 days, and the 30-day complication rate from 7.6 to 24.4% as the difficulty grade increased from 1 to 4/5 (both p < 0.001). In the CholeS cohort, a higher difficulty grade was found to be most strongly associated with conversion to open and 30-day mortality (AUROC = 0.903, 0.822, respectively). On multivariable analysis, the Nassar operative difficultly scale was found to be a significant independent predictor of operative duration, conversion to open surgery, 30-day complications and 30-day reintervention (all p < 0.001).
Conclusion
We have shown that an operative difficulty scale can standardise the description of operative findings by multiple grades of surgeons to facilitate audit, training assessment and research. It provides a tool for reporting operative findings, disease severity and technical difficulty and can be utilised in future research to reliably compare outcomes according to case mix and intra-operative difficulty
Management of intracranial tuberculous mass lesions: how long should we treat for? [version 3; peer review: 3 approved]
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence and HIV prevalence. The diagnosis of such lesions, which include tuberculoma and tuberculous abscesses, is often presumptive and based on radiological features, supportive evidence of TB elsewhere and response to TB treatment. However, the treatment response is unpredictable, with lesions frequently enlarging paradoxically or persisting for many years despite appropriate TB treatment and corticosteroid therapy. Most international guidelines recommend a 9-12 month course of TB treatment for central nervous system TB when the infecting Mycobacterium tuberculosis (M.tb) strain is sensitive to first-line drugs. However, there is variation in opinion and practice with respect to the duration of TB treatment in patients with tuberculomas or tuberculous abscesses. A major reason for this is the lack of prospective clinical trial evidence. Some experts suggest continuing treatment until radiological resolution of enhancing lesions has been achieved, but this may unnecessarily expose patients to prolonged periods of potentially toxic drugs. It is currently unknown whether persistent radiological enhancement of intracranial tuberculomas after 9-12 months of treatment represents active disease, inflammatory response in a sterilized lesion or merely revascularization. The consequences of stopping TB treatment prior to resolution of lesional enhancement have rarely been explored. These important issues were discussed at the 3rd International Tuberculous Meningitis Consortium meeting. Most clinicians were of the opinion that continued enhancement does not necessarily represent treatment failure and that prolonged TB therapy was not warranted in patients presumably infected with M.tb strains susceptible to first-line drugs. In this manuscript we highlight current medical treatment practices, benefits and disadvantages of different TB treatment durations and the need for evidence-based guidelines regarding the treatment duration of patients with intracranial tuberculous mass lesions
Missed opportunity for standardized diagnosis and treatment among adult Tuberculosis patients in hospitals involved in Public-Private Mix for Directly Observed Treatment Short-Course strategy in Indonesia: a cross-sectional study
Background: The engagement of hospitals in Public-Private Mix (PPM) for Directly Observed Treatment Short-Course
(DOTS) strategy has increased rapidly internationally - including in Indonesia. In view of the rapid global scaling-up of
hospital engagement, we aimed to estimate the proportion of outpatient adult Tuberculosis patients who received
standardized diagnosis and treatment at outpatients units of hospitals involved in the PPM-DOTS strategy.
Methods: A cross-sectional study using morbidity reports for outpatients, laboratory registers and Tuberculosis patient
registers from 1 January 2005 to 31 December 2005. By quota sampling, 62 hospitals were selected. Post-stratification
analysis was conducted to estimate the proportion of Tuberculosis cases receiving standardized management
according to the DOTS strategy.
Result: Nineteen to 53% of Tuberculosis cases and 4-18% of sputum smear positive Tuberculosis cases in hospitals that
participated in the PPM-DOTS strategy were not treated with standardized diagnosis and treatment as in DOTS.
Conclusion: This study found that a substantial proportion of TB patients cared for at PPM-DOTS hospitals are not
managed under the DOTS strategy. This represents a missed opportunity for standardized diagnoses and treatment. A
combination of strong individual commitment of health professionals, organizational supports, leadership, and
relevant policy in hospital and National Tuberculosis Programme may be required to strengthen DOTS implementation
in hospitals
Demonstration of Two-Qubit Algorithms with a Superconducting Quantum Processor
By harnessing the superposition and entanglement of physical states, quantum
computers could outperform their classical counterparts in solving problems of
technological impact, such as factoring large numbers and searching databases.
A quantum processor executes algorithms by applying a programmable sequence of
gates to an initialized register of qubits, which coherently evolves into a
final state containing the result of the computation. Simultaneously meeting
the conflicting requirements of long coherence, state preparation, universal
gate operations, and qubit readout makes building quantum processors
challenging. Few-qubit processors have already been shown in nuclear magnetic
resonance, cold ion trap and optical systems, but a solid-state realization has
remained an outstanding challenge. Here we demonstrate a two-qubit
superconducting processor and the implementation of the Grover search and
Deutsch-Jozsa quantum algorithms. We employ a novel two-qubit interaction,
tunable in strength by two orders of magnitude on nanosecond time scales, which
is mediated by a cavity bus in a circuit quantum electrodynamics (cQED)
architecture. This interaction allows generation of highly-entangled states
with concurrence up to 94%. Although this processor constitutes an important
step in quantum computing with integrated circuits, continuing efforts to
increase qubit coherence times, gate performance and register size will be
required to fulfill the promise of a scalable technology.Comment: 6 pages, 1 table, 4 figures, and Supplementary Information (3 pages,
3 figures); Expanded author list, updated references, and minor improvements
to text and figure
Tuberculous meningitis: new tools and new approaches required [version 1; peer review: not peer reviewed]
Tuberculous meningitis is the most severe form of tuberculosis and causes widespread mortality and morbidity. Understanding of the epidemiology and pathogenesis is incomplete, and the optimal diagnosis and treatment are poorly defined. To generate research collaboration and coordination, as well as to promote sharing of ideas and advocacy efforts, the International Tuberculous Meningitis Research Consortium was formed in 2009. During the most recent meeting of this group in Lucknow, India, in March 2019, the Consortium decided to bring together key articles on tuberculous meningitis in one supplement. The supplement covers recent scientific updates, expert perspectives on specific clinical challenges, consensus statements on how to conduct research, and a set of priorities for future investigation
The current global situation for tuberculous meningitis: Epidemiology, diagnostics, treatment and outcomes
Tuberculous meningitis (TBM) results from dissemination of M. tuberculosis to the cerebrospinal fluid (CSF) and meninges. Ischaemia, hydrocephalus and raised intracranial pressure frequently result, leading to extensive brain injury and neurodisability. The global burden of TBM is unclear and it is likely that many cases are undiagnosed, with many treated cases unreported. Untreated, TBM is uniformly fatal, and even if treated, mortality and morbidity are high. Young age and human immunodeficiency virus (HIV) infection are potent risk factors for TBM, while Bacillus Calmette-Guérin (BCG) vaccination is protective, particularly in young children. Diagnosis of TBM usually relies on characteristic clinical symptoms and signs, together with consistent neuroimaging and CSF parameters. The ability to confirm the TBM diagnosis via CSF isolation of M. tuberculosis depends on the type of diagnostic tests available. In most cases, the diagnosis remains unconfirmed. GeneXpert MTB/RIF and the next generation Xpert Ultra offer improved sensitivity and rapid turnaround times, and while roll-out has scaled up, availability remains limited. Many locations rely only on acid fast bacilli smear, which is insensitive. Treatment regimens for TBM are based on evidence for pulmonary tuberculosis treatment, with little consideration to CSF penetration or mode of drug action required. The World Health Organization recommends a 12-month treatment course, although data on which to base this duration is lacking. New treatment regimens and drug dosages are under evaluation, with much higher dosages of rifampicin and the inclusion of fluoroquinolones and linezolid identified as promising innovations. The inclusion of corticosteroids at the start of treatment has been demonstrated to reduce mortality in HIV-negative individuals but whether they are universally beneficial is unclear. Other host-directed therapies show promise but evidence for widespread use is lacking. Finally, the management of TBM within health systems is sub-optimal, with drop-offs at every stage in the care cascade
- …